241 related articles for article (PubMed ID: 31056310)
21. Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome.
Reichman DE; Goldschlag D; Rosenwaks Z
Fertil Steril; 2014 Apr; 101(4):1012-8.e1. PubMed ID: 24491452
[TBL] [Abstract][Full Text] [Related]
22. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
[TBL] [Abstract][Full Text] [Related]
23. Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred.
Gleicher N; Vega MV; Darmon SK; Weghofer A; Wu YG; Wang Q; Zhang L; Albertini DF; Barad DH; Kushnir VA
Fertil Steril; 2015 Dec; 104(6):1435-41. PubMed ID: 26348275
[TBL] [Abstract][Full Text] [Related]
24. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles.
Baker VL; Brown MB; Luke B; Smith GW; Ireland JJ
Fertil Steril; 2015 Nov; 104(5):1145-52.e1-5. PubMed ID: 26297646
[TBL] [Abstract][Full Text] [Related]
25. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
[TBL] [Abstract][Full Text] [Related]
26. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
27. Combinational approach of retrospective clinical evidence and transcriptomics highlight AMH superiority to FSH, as successful ICSI outcome predictor.
Kastora SL; Triantafyllidou O; Kolovos G; Kastoras A; Sigalos G; Vlahos N
J Assist Reprod Genet; 2020 Jul; 37(7):1623-1635. PubMed ID: 32430730
[TBL] [Abstract][Full Text] [Related]
28. Granulocyte colony-stimulating factor priming improves embryos and pregnancy rate in patients with poor ovarian reserve: a randomized controlled trial.
Jinno M; Tamaoka Y; Teruya K; Watanabe A; Hatakeyama N; Goda T; Kimata H; Jinno Y
Reprod Biol Endocrinol; 2023 Mar; 21(1):29. PubMed ID: 36944952
[TBL] [Abstract][Full Text] [Related]
29. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
Lukaszuk K; Liss J; Kunicki M; Jakiel G; Wasniewski T; Woclawek-Potocka I; Pastuszek E
Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
[TBL] [Abstract][Full Text] [Related]
30. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.
Guo Y; Liu S; Hu S; Li F; Jin L
Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349
[TBL] [Abstract][Full Text] [Related]
31. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
32. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
Crawford S; Boulet SL; Kawwass JF; Jamieson DJ; Kissin DM
Fertil Steril; 2017 Jan; 107(1):110-118. PubMed ID: 27842997
[TBL] [Abstract][Full Text] [Related]
33. Predicting personalized cumulative live birth following in vitro fertilization.
McLernon DJ; Raja EA; Toner JP; Baker VL; Doody KJ; Seifer DB; Sparks AE; Wantman E; Lin PC; Bhattacharya S; Van Voorhis BJ
Fertil Steril; 2022 Feb; 117(2):326-338. PubMed ID: 34674824
[TBL] [Abstract][Full Text] [Related]
34. Randomized, assessor-blind, antimüllerian hormone-stratified, dose-response trial in Japanese in vitro fertilization/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta.
Ishihara O; Klein BM; Arce JC;
Fertil Steril; 2021 Jun; 115(6):1478-1486. PubMed ID: 33272623
[TBL] [Abstract][Full Text] [Related]
35. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
[TBL] [Abstract][Full Text] [Related]
36. Age effect on in vitro fertilization pregnancy mediated by anti-Mullerian hormone (AMH) and modified by follicle stimulating hormone (FSH).
Hsieh HC; Su JY; Wang S; Huang YT
BMC Pregnancy Childbirth; 2020 Apr; 20(1):209. PubMed ID: 32272911
[TBL] [Abstract][Full Text] [Related]
37. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.
La Marca A; Minasi MG; Sighinolfi G; Greco P; Argento C; Grisendi V; Fiorentino F; Greco E
Fertil Steril; 2017 Nov; 108(5):777-783.e2. PubMed ID: 28987789
[TBL] [Abstract][Full Text] [Related]
38. Antimüllerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng/mL versus 1-4 ng/mL.
Kavoussi SK; Odenwald KC; Boehnlein LM; Summers-Colquitt RB; Pool TB; Swain JE; Jones JM; Lindstrom MJ; Lebovic DI
Fertil Steril; 2015 Sep; 104(3):633-6. PubMed ID: 26144573
[TBL] [Abstract][Full Text] [Related]
39. Basal Serum Anti-Müllerian Hormone Level as a Predictor of Clinical Outcomes in Freezing-all Embryo Transfer Program.
Li XL; Huang R; Fang C; Liang XY
Curr Med Sci; 2018 Oct; 38(5):861-867. PubMed ID: 30341521
[TBL] [Abstract][Full Text] [Related]
40. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
